Synthetic Gene Circuit Cell Products

Creative Biolabs uses advanced synthetic gene circuit technology to precisely regulate cellular behavior, enabling cells to exhibit powerful targeting and killing capabilities in the tumor microenvironment. Additionally, our cellular products are equipped with a smart adaptive regulation mechanism that allows them to sense changes in the tumor microenvironment in real-time and adjust their activity accordingly. Moving beyond a singular approach to anticancer treatment, our cellular products incorporate a multifaceted functionality that can simultaneously activate the immune response, suppress tumors, and promote inflammatory reactions, significantly enhancing therapeutic efficacy.

Introduction

In recent years, cell products designed using synthetic gene circuit technology have held significant promise in the realm of cancer immunotherapy. As a result, Creative Biolabs uses synthetic gene circuit design tools to create cell products capable of specifically targeting tumors.

Our approach enhances the functionality of various cell types by incorporating expression elements for cytokines such as IL-2 and IL-12, thereby boosting cell proliferation and efficacy. Meanwhile, we integrate these engineered gene circuits into expression vectors and introduce them into target cells through methods like electroporation and viral transduction. Moreover, we have assessed the functionality of all synthetic gene circuit cell products under in vitro conditions, measuring factors such as cell proliferation, cytotoxicity, and cytokine secretion. In addition, the antitumor effectiveness, safety, and tolerability of the cell products are evaluated using animal models.

Fig.1 Synthetic Gene Circuit-based Assay for Cancer immunotherapy.¹

Products

At Creative Biolabs, our synthetic gene circuit cell products have been developed and broadly used in immunotherapies targeting prevalent cancer types, including melanoma, leukemia, and lymphoma. The personalized design of these products can enhance therapeutic outcomes while minimizing side effects. We are confident that our synthetic gene circuit cell products will open new avenues in the field of cancer immunotherapy.

Features

Nowadays, Creative Biolabs maintains high standards and strict requirements for product quality. We implement rigorous testing and quality control procedures at every stage, from raw material procurement to product delivery, ensuring that each batch of synthetic gene circuit cell products meets the highest industry standards.

• Targeted Precision: Our synthetic gene circuit cell products are engineered to specifically target certain tumor antigens, minimizing damage to healthy cells and reducing side effects.
• Efficient Proliferation: Utilizing synthetic genetic circuits, our cell products exhibit a robust ability to proliferate within the tumor microenvironment, continuously enhancing their anti-tumor effects.
• Dynamic Feedback: Our synthetic gene circuit cells can promptly adjust their functions in response to changes in tumor cells, creating a straightforward "feedback loop" for effective dynamic response.
• High Safety Profile: Following rigorous safety assessments and QC validations, our synthetic gene circuit cell products are designed to minimize adverse reactions during the treatment process.
• High Scalability: Our synthetic gene circuit cells exhibit excellent scalability, allowing for customization according to various tumor types and project differences, thereby catering to a broader range of clients' needs.

In the field of cancer immunotherapy, the synergy between innovation and science remains the driving force behind advancements in treatment. Creative Biolabs is proud to introduce a series of cell products developed through the design of synthetic gene circuits, providing new hope for cancer immunotherapy. Our cell product not only possesses distinctive biological characteristics but also achieves groundbreaking improvements in both efficacy and safety. If you are interested in our synthetic gene circuits cell products or would like to receive more information, please feel free to contact us anytime.

Reference

1. Zhang, Chao, et al. "Synthetic gene circuit-based assay with multilevel switch enables background-free and absolute quantification of circulating tumor DNA." Research 6 (2023): 0217. Distributed under Open Access license CC BY 4.0, without modification.